ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Soft-Contact Blood Lancet Market Research Report 2026
Published Date: 2026-01-07
|
Report Code: QYRE-Auto-30Y19935
Home | Market Reports | Health| Medical Devices & Equipment
Global Soft Contact Blood Lancet Market Research Report 2026
BUY CHAPTERS

Global Soft-Contact Blood Lancet Market Research Report 2026

Code: QYRE-Auto-30Y19935
Report
2026-01-07
Pages:138
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Roche
LifeScan Inc
BD
MTD Group
Greiner Bio One
Owen Mumford
Cardinal Health
Ascensia
Abbott
B. Braun
Terumo
i-Sens
Nipro
ICU Medical
Sarstedt
Yuwell Medical
Tianjin Huahong
Shandong Lianfa
Sannuo Biosensor
Suzhou Slink Medical
Puan Medical

Soft-Contact Blood Lancet Market Size

The global Soft-Contact Blood Lancet market was valued at US$ 962 million in 2025 and is anticipated to reach US$ 1313 million by 2032, at a CAGR of 4.6% from 2026 to 2032.

Soft-Contact Blood Lancet Market

Soft-Contact Blood Lancet Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Soft-Contact Blood Lancet competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
In 2025, the global annual production capacity of soft-contact blood lancets was approximately 19.5 billion units, while actual output reached around 16.03 billion units. The global average selling price was approximately US$0.060 per unit. Supported by large-scale automated manufacturing and stable demand from chronic disease management, major manufacturers maintained gross profit margins in the range of 30%–45%. Soft-contact blood lancets are disposable medical devices used for capillary blood sampling. They incorporate a soft-contact or pressure-activated mechanism that minimizes skin trauma and reduces pain during puncture while ensuring consistent penetration depth. These lancets are widely applied in blood glucose monitoring, point-of-care testing, and home healthcare scenarios.
Upstream of the soft-contact blood lancet supply chain consists of medical-grade stainless steel needles, polymer resins, spring components, packaging materials, and sterilization consumables. Midstream manufacturers focus on precision injection molding, needle grinding, automated assembly, sterilization, and quality control, with major production centers located in China, the United States, Europe, and Southeast Asia. Downstream channels include hospitals, diagnostic laboratories, pharmacies, medical distributors, and home healthcare brands. End users place strong emphasis on safety, pain reduction, sterility assurance, consistency, and compatibility with various lancing devices.
The soft-contact blood lancet market in 2025 is supported by the continued rise in diabetes prevalence and the expansion of home-based healthcare. Compared with traditional lancets, soft-contact designs provide better user comfort and improved sampling consistency, driving their gradual replacement of conventional products. Although unit prices remain relatively low, high shipment volumes and automated manufacturing enable suppliers to maintain stable margins. Regulatory compliance and sterilization standards remain key barriers to entry. Future growth will be driven by chronic disease management, aging populations, and increasing healthcare accessibility in emerging markets.
This report delivers a comprehensive overview of the global Soft-Contact Blood Lancet market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Soft-Contact Blood Lancet. The Soft-Contact Blood Lancet market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Soft-Contact Blood Lancet market comprehensively. Regional market sizes by Type, by Application, by Length, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Soft-Contact Blood Lancet manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Soft-Contact Blood Lancet Market Report

Report Metric Details
Report Name Soft-Contact Blood Lancet Market
Accounted market size in 2025 US$ 962 million
Forecasted market size in 2032 US$ 1313 million
CAGR 4.6%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Safety
  • Routine
Segment by Length
  • Standard Length
  • Short-length
  • Long-length
by Application
  • Newborn Screening
  • Blood Glucose Test
  • Rapid Complete Blood Count
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Roche, Lifescan, BD, MTD Group, Greiner Bio One, Owen Mumford, Cardinal Health, Ascensia, Abbott, B. Braun, Terumo, I-SENS, Nipro, ICU Medical, Sarstedt, Sannuo Biosensor, Yuwell Medical, Tianjin Huahong, Suzhou Slink Medical, Shandong Lianfa, Puan Medical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Length, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Soft-Contact Blood Lancet manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Soft-Contact Blood Lancet sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Soft-Contact Blood Lancet Market growing?

Ans: The Soft-Contact Blood Lancet Market witnessing a CAGR of 4.6% during the forecast period 2026-2032.

What is the Soft-Contact Blood Lancet Market size in 2032?

Ans: The Soft-Contact Blood Lancet Market size in 2032 will be US$ 1313 million.

Who are the main players in the Soft-Contact Blood Lancet Market report?

Ans: The main players in the Soft-Contact Blood Lancet Market are Roche, Lifescan, BD, MTD Group, Greiner Bio One, Owen Mumford, Cardinal Health, Ascensia, Abbott, B. Braun, Terumo, I-SENS, Nipro, ICU Medical, Sarstedt, Sannuo Biosensor, Yuwell Medical, Tianjin Huahong, Suzhou Slink Medical, Shandong Lianfa, Puan Medical

What are the Application segmentation covered in the Soft-Contact Blood Lancet Market report?

Ans: The Applications covered in the Soft-Contact Blood Lancet Market report are Newborn Screening, Blood Glucose Test, Rapid Complete Blood Count, Others

What are the Type segmentation covered in the Soft-Contact Blood Lancet Market report?

Ans: The Types covered in the Soft-Contact Blood Lancet Market report are Safety, Routine

1 Soft-Contact Blood Lancet Market Overview
1.1 Product Definition
1.2 Soft-Contact Blood Lancet by Type
1.2.1 Global Soft-Contact Blood Lancet Market Value by Type: 2025 vs 2032
1.2.2 Safety
1.2.3 Routine
1.3 Soft-Contact Blood Lancet by Length
1.3.1 Global Soft-Contact Blood Lancet Market Value by Length: 2025 vs 2032
1.3.2 Standard Length
1.3.3 Short-length
1.3.4 Long-length
1.4 Soft-Contact Blood Lancet by Application
1.4.1 Global Soft-Contact Blood Lancet Market Value by Application: 2025 vs 2032
1.4.2 Newborn Screening
1.4.3 Blood Glucose Test
1.4.4 Rapid Complete Blood Count
1.4.5 Others
1.5 Global Soft-Contact Blood Lancet Market Size Estimates and Forecasts
1.5.1 Global Soft-Contact Blood Lancet Revenue 2021–2032
1.5.2 Global Soft-Contact Blood Lancet Sales 2021–2032
1.5.3 Global Soft-Contact Blood Lancet Market Average Price (2021–2032)
1.6 Assumptions and Limitations
2 Soft-Contact Blood Lancet Market Competition by Manufacturers
2.1 Global Soft-Contact Blood Lancet Sales Market Share by Manufacturers (2021–2026)
2.2 Global Soft-Contact Blood Lancet Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Soft-Contact Blood Lancet Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Soft-Contact Blood Lancet, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Soft-Contact Blood Lancet, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Soft-Contact Blood Lancet, Product Types and Applications
2.7 Global Key Manufacturers of Soft-Contact Blood Lancet, Date of Entry into the Industry
2.8 Global Soft-Contact Blood Lancet Market Competitive Situation and Trends
2.8.1 Global Soft-Contact Blood Lancet Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Soft-Contact Blood Lancet Players Market Share by Revenue
2.8.3 Global Soft-Contact Blood Lancet Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Soft-Contact Blood Lancet Market Scenario by Region
3.1 Global Soft-Contact Blood Lancet Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Soft-Contact Blood Lancet Sales by Region: 2021–2032
3.2.1 Global Soft-Contact Blood Lancet Sales by Region: 2021–2026
3.2.2 Global Soft-Contact Blood Lancet Sales by Region: 2027–2032
3.3 Global Soft-Contact Blood Lancet Revenue by Region: 2021–2032
3.3.1 Global Soft-Contact Blood Lancet Revenue by Region: 2021–2026
3.3.2 Global Soft-Contact Blood Lancet Revenue by Region: 2027–2032
3.4 North America Soft-Contact Blood Lancet Market Facts & Figures by Country
3.4.1 North America Soft-Contact Blood Lancet Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Soft-Contact Blood Lancet Sales by Country (2021–2032)
3.4.3 North America Soft-Contact Blood Lancet Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Soft-Contact Blood Lancet Market Facts & Figures by Country
3.5.1 Europe Soft-Contact Blood Lancet Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Soft-Contact Blood Lancet Sales by Country (2021–2032)
3.5.3 Europe Soft-Contact Blood Lancet Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Soft-Contact Blood Lancet Market Facts & Figures by Region
3.6.1 Asia Pacific Soft-Contact Blood Lancet Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Soft-Contact Blood Lancet Sales by Region (2021–2032)
3.6.3 Asia Pacific Soft-Contact Blood Lancet Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Soft-Contact Blood Lancet Market Facts & Figures by Country
3.7.1 Latin America Soft-Contact Blood Lancet Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Soft-Contact Blood Lancet Sales by Country (2021–2032)
3.7.3 Latin America Soft-Contact Blood Lancet Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Soft-Contact Blood Lancet Market Facts & Figures by Country
3.8.1 Middle East and Africa Soft-Contact Blood Lancet Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Soft-Contact Blood Lancet Sales by Country (2021–2032)
3.8.3 Middle East and Africa Soft-Contact Blood Lancet Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Soft-Contact Blood Lancet Sales by Type (2021–2032)
4.1.1 Global Soft-Contact Blood Lancet Sales by Type (2021–2026)
4.1.2 Global Soft-Contact Blood Lancet Sales by Type (2027–2032)
4.1.3 Global Soft-Contact Blood Lancet Sales Market Share by Type (2021–2032)
4.2 Global Soft-Contact Blood Lancet Revenue by Type (2021–2032)
4.2.1 Global Soft-Contact Blood Lancet Revenue by Type (2021–2026)
4.2.2 Global Soft-Contact Blood Lancet Revenue by Type (2027–2032)
4.2.3 Global Soft-Contact Blood Lancet Revenue Market Share by Type (2021–2032)
4.3 Global Soft-Contact Blood Lancet Price by Type (2021–2032)
5 Segment by Application
5.1 Global Soft-Contact Blood Lancet Sales by Application (2021–2032)
5.1.1 Global Soft-Contact Blood Lancet Sales by Application (2021–2026)
5.1.2 Global Soft-Contact Blood Lancet Sales by Application (2027–2032)
5.1.3 Global Soft-Contact Blood Lancet Sales Market Share by Application (2021–2032)
5.2 Global Soft-Contact Blood Lancet Revenue by Application (2021–2032)
5.2.1 Global Soft-Contact Blood Lancet Revenue by Application (2021–2026)
5.2.2 Global Soft-Contact Blood Lancet Revenue by Application (2027–2032)
5.2.3 Global Soft-Contact Blood Lancet Revenue Market Share by Application (2021–2032)
5.3 Global Soft-Contact Blood Lancet Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Company Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Soft-Contact Blood Lancet Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Roche Soft-Contact Blood Lancet Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Lifescan
6.2.1 Lifescan Company Information
6.2.2 Lifescan Description and Business Overview
6.2.3 Lifescan Soft-Contact Blood Lancet Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Lifescan Soft-Contact Blood Lancet Product Portfolio
6.2.5 Lifescan Recent Developments/Updates
6.3 BD
6.3.1 BD Company Information
6.3.2 BD Description and Business Overview
6.3.3 BD Soft-Contact Blood Lancet Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 BD Soft-Contact Blood Lancet Product Portfolio
6.3.5 BD Recent Developments/Updates
6.4 MTD Group
6.4.1 MTD Group Company Information
6.4.2 MTD Group Description and Business Overview
6.4.3 MTD Group Soft-Contact Blood Lancet Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 MTD Group Soft-Contact Blood Lancet Product Portfolio
6.4.5 MTD Group Recent Developments/Updates
6.5 Greiner Bio One
6.5.1 Greiner Bio One Company Information
6.5.2 Greiner Bio One Description and Business Overview
6.5.3 Greiner Bio One Soft-Contact Blood Lancet Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Greiner Bio One Soft-Contact Blood Lancet Product Portfolio
6.5.5 Greiner Bio One Recent Developments/Updates
6.6 Owen Mumford
6.6.1 Owen Mumford Company Information
6.6.2 Owen Mumford Description and Business Overview
6.6.3 Owen Mumford Soft-Contact Blood Lancet Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Owen Mumford Soft-Contact Blood Lancet Product Portfolio
6.6.5 Owen Mumford Recent Developments/Updates
6.7 Cardinal Health
6.7.1 Cardinal Health Company Information
6.7.2 Cardinal Health Description and Business Overview
6.7.3 Cardinal Health Soft-Contact Blood Lancet Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Cardinal Health Soft-Contact Blood Lancet Product Portfolio
6.7.5 Cardinal Health Recent Developments/Updates
6.8 Ascensia
6.8.1 Ascensia Company Information
6.8.2 Ascensia Description and Business Overview
6.8.3 Ascensia Soft-Contact Blood Lancet Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Ascensia Soft-Contact Blood Lancet Product Portfolio
6.8.5 Ascensia Recent Developments/Updates
6.9 Abbott
6.9.1 Abbott Company Information
6.9.2 Abbott Description and Business Overview
6.9.3 Abbott Soft-Contact Blood Lancet Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Abbott Soft-Contact Blood Lancet Product Portfolio
6.9.5 Abbott Recent Developments/Updates
6.10 B. Braun
6.10.1 B. Braun Company Information
6.10.2 B. Braun Description and Business Overview
6.10.3 B. Braun Soft-Contact Blood Lancet Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 B. Braun Soft-Contact Blood Lancet Product Portfolio
6.10.5 B. Braun Recent Developments/Updates
6.11 Terumo
6.11.1 Terumo Company Information
6.11.2 Terumo Description and Business Overview
6.11.3 Terumo Soft-Contact Blood Lancet Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Terumo Soft-Contact Blood Lancet Product Portfolio
6.11.5 Terumo Recent Developments/Updates
6.12 I-SENS
6.12.1 I-SENS Company Information
6.12.2 I-SENS Description and Business Overview
6.12.3 I-SENS Soft-Contact Blood Lancet Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 I-SENS Soft-Contact Blood Lancet Product Portfolio
6.12.5 I-SENS Recent Developments/Updates
6.13 Nipro
6.13.1 Nipro Company Information
6.13.2 Nipro Description and Business Overview
6.13.3 Nipro Soft-Contact Blood Lancet Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Nipro Soft-Contact Blood Lancet Product Portfolio
6.13.5 Nipro Recent Developments/Updates
6.14 ICU Medical
6.14.1 ICU Medical Company Information
6.14.2 ICU Medical Description and Business Overview
6.14.3 ICU Medical Soft-Contact Blood Lancet Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 ICU Medical Soft-Contact Blood Lancet Product Portfolio
6.14.5 ICU Medical Recent Developments/Updates
6.15 Sarstedt
6.15.1 Sarstedt Company Information
6.15.2 Sarstedt Description and Business Overview
6.15.3 Sarstedt Soft-Contact Blood Lancet Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Sarstedt Soft-Contact Blood Lancet Product Portfolio
6.15.5 Sarstedt Recent Developments/Updates
6.16 Sannuo Biosensor
6.16.1 Sannuo Biosensor Company Information
6.16.2 Sannuo Biosensor Description and Business Overview
6.16.3 Sannuo Biosensor Soft-Contact Blood Lancet Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Sannuo Biosensor Soft-Contact Blood Lancet Product Portfolio
6.16.5 Sannuo Biosensor Recent Developments/Updates
6.17 Yuwell Medical
6.17.1 Yuwell Medical Company Information
6.17.2 Yuwell Medical Description and Business Overview
6.17.3 Yuwell Medical Soft-Contact Blood Lancet Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Yuwell Medical Soft-Contact Blood Lancet Product Portfolio
6.17.5 Yuwell Medical Recent Developments/Updates
6.18 Tianjin Huahong
6.18.1 Tianjin Huahong Company Information
6.18.2 Tianjin Huahong Description and Business Overview
6.18.3 Tianjin Huahong Soft-Contact Blood Lancet Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Tianjin Huahong Soft-Contact Blood Lancet Product Portfolio
6.18.5 Tianjin Huahong Recent Developments/Updates
6.19 Suzhou Slink Medical
6.19.1 Suzhou Slink Medical Company Information
6.19.2 Suzhou Slink Medical Description and Business Overview
6.19.3 Suzhou Slink Medical Soft-Contact Blood Lancet Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Suzhou Slink Medical Soft-Contact Blood Lancet Product Portfolio
6.19.5 Suzhou Slink Medical Recent Developments/Updates
6.20 Shandong Lianfa
6.20.1 Shandong Lianfa Company Information
6.20.2 Shandong Lianfa Description and Business Overview
6.20.3 Shandong Lianfa Soft-Contact Blood Lancet Sales, Revenue, and Gross Margin (2021–2026)
6.20.4 Shandong Lianfa Soft-Contact Blood Lancet Product Portfolio
6.20.5 Shandong Lianfa Recent Developments/Updates
6.21 Puan Medical
6.21.1 Puan Medical Company Information
6.21.2 Puan Medical Description and Business Overview
6.21.3 Puan Medical Soft-Contact Blood Lancet Sales, Revenue, and Gross Margin (2021–2026)
6.21.4 Puan Medical Soft-Contact Blood Lancet Product Portfolio
6.21.5 Puan Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Soft-Contact Blood Lancet Industry Chain Analysis
7.2 Soft-Contact Blood Lancet Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Soft-Contact Blood Lancet Production Mode & Process Analysis
7.4 Soft-Contact Blood Lancet Sales and Marketing
7.4.1 Soft-Contact Blood Lancet Sales Channels
7.4.2 Soft-Contact Blood Lancet Distributors
7.5 Soft-Contact Blood Lancet Customer Analysis
8 Soft-Contact Blood Lancet Market Dynamics
8.1 Soft-Contact Blood Lancet Industry Trends
8.2 Soft-Contact Blood Lancet Market Drivers
8.3 Soft-Contact Blood Lancet Market Challenges
8.4 Soft-Contact Blood Lancet Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Roche
LifeScan Inc
BD
MTD Group
Greiner Bio One
Owen Mumford
Cardinal Health
Ascensia
Abbott
B. Braun
Terumo
i-Sens
Nipro
ICU Medical
Sarstedt
Yuwell Medical
Tianjin Huahong
Shandong Lianfa
Sannuo Biosensor
Suzhou Slink Medical
Puan Medical
List of Tables
 Table 1. Global Soft-Contact Blood Lancet Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Soft-Contact Blood Lancet Market Value by Length (US$ Million), 2025 vs 2032
 Table 3. Global Soft-Contact Blood Lancet Market Value by Application (US$ Million), 2025 vs 2032
 Table 4. Global Soft-Contact Blood Lancet Market Competitive Situation by Manufacturers in 2025
 Table 5. Global Soft-Contact Blood Lancet Sales (K Units) of Key Manufacturers (2021–2026)
 Table 6. Global Soft-Contact Blood Lancet Sales Market Share by Manufacturers (2021–2026)
 Table 7. Global Soft-Contact Blood Lancet Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 8. Global Soft-Contact Blood Lancet Revenue Share by Manufacturers (2021–2026)
 Table 9. Global Market Soft-Contact Blood Lancet Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 10. Global Key Players of Soft-Contact Blood Lancet, Industry Ranking, 2023 vs 2024 vs 2025
 Table 11. Global Key Manufacturers of Soft-Contact Blood Lancet, Manufacturing Sites and Headquarters
 Table 12. Global Key Manufacturers of Soft-Contact Blood Lancet, Product Types and Applications
 Table 13. Global Key Manufacturers of Soft-Contact Blood Lancet, Date of Entry into the Industry
 Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 15. Global Soft-Contact Blood Lancet Companies by Tier (Tier 1, Tier 2, Tier 3), based on Soft-Contact Blood Lancet Revenue, 2025
 Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 17. Global Soft-Contact Blood Lancet Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 18. Global Soft-Contact Blood Lancet Sales by Region (K Units), 2021–2026
 Table 19. Global Soft-Contact Blood Lancet Sales Market Share by Region (2021–2026)
 Table 20. Global Soft-Contact Blood Lancet Sales by Region (K Units), 2027–2032
 Table 21. Global Soft-Contact Blood Lancet Sales Market Share by Region (2027–2032)
 Table 22. Global Soft-Contact Blood Lancet Revenue by Region (US$ Million), 2021–2026
 Table 23. Global Soft-Contact Blood Lancet Revenue Market Share by Region (2021–2026)
 Table 24. Global Soft-Contact Blood Lancet Revenue by Region (US$ Million), 2027–2032
 Table 25. Global Soft-Contact Blood Lancet Revenue Market Share by Region (2027–2032)
 Table 26. North America Soft-Contact Blood Lancet Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 27. North America Soft-Contact Blood Lancet Sales by Country (K Units), 2021–2026
 Table 28. North America Soft-Contact Blood Lancet Sales by Country (K Units), 2027–2032
 Table 29. North America Soft-Contact Blood Lancet Revenue by Country (US$ Million), 2021–2026
 Table 30. North America Soft-Contact Blood Lancet Revenue by Country (US$ Million), 2027–2032
 Table 31. Europe Soft-Contact Blood Lancet Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 32. Europe Soft-Contact Blood Lancet Sales by Country (K Units), 2021–2026
 Table 33. Europe Soft-Contact Blood Lancet Sales by Country (K Units), 2027–2032
 Table 34. Europe Soft-Contact Blood Lancet Revenue by Country (US$ Million), 2021–2026
 Table 35. Europe Soft-Contact Blood Lancet Revenue by Country (US$ Million), 2027–2032
 Table 36. Asia Pacific Soft-Contact Blood Lancet Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 37. Asia Pacific Soft-Contact Blood Lancet Sales by Region (K Units), 2021–2026
 Table 38. Asia Pacific Soft-Contact Blood Lancet Sales by Region (K Units), 2027–2032
 Table 39. Asia Pacific Soft-Contact Blood Lancet Revenue by Region (US$ Million), 2021–2026
 Table 40. Asia Pacific Soft-Contact Blood Lancet Revenue by Region (US$ Million), 2027–2032
 Table 41. Latin America Soft-Contact Blood Lancet Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 42. Latin America Soft-Contact Blood Lancet Sales by Country (K Units), 2021–2026
 Table 43. Latin America Soft-Contact Blood Lancet Sales by Country (K Units), 2027–2032
 Table 44. Latin America Soft-Contact Blood Lancet Revenue by Country (US$ Million), 2021–2026
 Table 45. Latin America Soft-Contact Blood Lancet Revenue by Country (US$ Million), 2027–2032
 Table 46. Middle East and Africa Soft-Contact Blood Lancet Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 47. Middle East and Africa Soft-Contact Blood Lancet Sales by Country (K Units), 2021–2026
 Table 48. Middle East and Africa Soft-Contact Blood Lancet Sales by Country (K Units), 2027–2032
 Table 49. Middle East and Africa Soft-Contact Blood Lancet Revenue by Country (US$ Million), 2021–2026
 Table 50. Middle East and Africa Soft-Contact Blood Lancet Revenue by Country (US$ Million), 2027–2032
 Table 51. Global Soft-Contact Blood Lancet Sales (K Units) by Type (2021–2026)
 Table 52. Global Soft-Contact Blood Lancet Sales (K Units) by Type (2027–2032)
 Table 53. Global Soft-Contact Blood Lancet Sales Market Share by Type (2021–2026)
 Table 54. Global Soft-Contact Blood Lancet Sales Market Share by Type (2027–2032)
 Table 55. Global Soft-Contact Blood Lancet Revenue (US$ Million) by Type (2021–2026)
 Table 56. Global Soft-Contact Blood Lancet Revenue (US$ Million) by Type (2027–2032)
 Table 57. Global Soft-Contact Blood Lancet Revenue Market Share by Type (2021–2026)
 Table 58. Global Soft-Contact Blood Lancet Revenue Market Share by Type (2027–2032)
 Table 59. Global Soft-Contact Blood Lancet Price (US$/Unit) by Type (2021–2026)
 Table 60. Global Soft-Contact Blood Lancet Price (US$/Unit) by Type (2027–2032)
 Table 61. Global Soft-Contact Blood Lancet Sales (K Units) by Application (2021–2026)
 Table 62. Global Soft-Contact Blood Lancet Sales (K Units) by Application (2027–2032)
 Table 63. Global Soft-Contact Blood Lancet Sales Market Share by Application (2021–2026)
 Table 64. Global Soft-Contact Blood Lancet Sales Market Share by Application (2027–2032)
 Table 65. Global Soft-Contact Blood Lancet Revenue (US$ Million) by Application (2021–2026)
 Table 66. Global Soft-Contact Blood Lancet Revenue (US$ Million) by Application (2027–2032)
 Table 67. Global Soft-Contact Blood Lancet Revenue Market Share by Application (2021–2026)
 Table 68. Global Soft-Contact Blood Lancet Revenue Market Share by Application (2027–2032)
 Table 69. Global Soft-Contact Blood Lancet Price (US$/Unit) by Application (2021–2026)
 Table 70. Global Soft-Contact Blood Lancet Price (US$/Unit) by Application (2027–2032)
 Table 71. Roche Company Information
 Table 72. Roche Description and Business Overview
 Table 73. Roche Soft-Contact Blood Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 74. Roche Soft-Contact Blood Lancet Product
 Table 75. Roche Recent Developments/Updates
 Table 76. Lifescan Company Information
 Table 77. Lifescan Description and Business Overview
 Table 78. Lifescan Soft-Contact Blood Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 79. Lifescan Soft-Contact Blood Lancet Product
 Table 80. Lifescan Recent Developments/Updates
 Table 81. BD Company Information
 Table 82. BD Description and Business Overview
 Table 83. BD Soft-Contact Blood Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 84. BD Soft-Contact Blood Lancet Product
 Table 85. BD Recent Developments/Updates
 Table 86. MTD Group Company Information
 Table 87. MTD Group Description and Business Overview
 Table 88. MTD Group Soft-Contact Blood Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 89. MTD Group Soft-Contact Blood Lancet Product
 Table 90. MTD Group Recent Developments/Updates
 Table 91. Greiner Bio One Company Information
 Table 92. Greiner Bio One Description and Business Overview
 Table 93. Greiner Bio One Soft-Contact Blood Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 94. Greiner Bio One Soft-Contact Blood Lancet Product
 Table 95. Greiner Bio One Recent Developments/Updates
 Table 96. Owen Mumford Company Information
 Table 97. Owen Mumford Description and Business Overview
 Table 98. Owen Mumford Soft-Contact Blood Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 99. Owen Mumford Soft-Contact Blood Lancet Product
 Table 100. Owen Mumford Recent Developments/Updates
 Table 101. Cardinal Health Company Information
 Table 102. Cardinal Health Description and Business Overview
 Table 103. Cardinal Health Soft-Contact Blood Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 104. Cardinal Health Soft-Contact Blood Lancet Product
 Table 105. Cardinal Health Recent Developments/Updates
 Table 106. Ascensia Company Information
 Table 107. Ascensia Description and Business Overview
 Table 108. Ascensia Soft-Contact Blood Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 109. Ascensia Soft-Contact Blood Lancet Product
 Table 110. Ascensia Recent Developments/Updates
 Table 111. Abbott Company Information
 Table 112. Abbott Description and Business Overview
 Table 113. Abbott Soft-Contact Blood Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 114. Abbott Soft-Contact Blood Lancet Product
 Table 115. Abbott Recent Developments/Updates
 Table 116. B. Braun Company Information
 Table 117. B. Braun Description and Business Overview
 Table 118. B. Braun Soft-Contact Blood Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 119. B. Braun Soft-Contact Blood Lancet Product
 Table 120. B. Braun Recent Developments/Updates
 Table 121. Terumo Company Information
 Table 122. Terumo Description and Business Overview
 Table 123. Terumo Soft-Contact Blood Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 124. Terumo Soft-Contact Blood Lancet Product
 Table 125. Terumo Recent Developments/Updates
 Table 126. I-SENS Company Information
 Table 127. I-SENS Description and Business Overview
 Table 128. I-SENS Soft-Contact Blood Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 129. I-SENS Soft-Contact Blood Lancet Product
 Table 130. I-SENS Recent Developments/Updates
 Table 131. Nipro Company Information
 Table 132. Nipro Description and Business Overview
 Table 133. Nipro Soft-Contact Blood Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 134. Nipro Soft-Contact Blood Lancet Product
 Table 135. Nipro Recent Developments/Updates
 Table 136. ICU Medical Company Information
 Table 137. ICU Medical Description and Business Overview
 Table 138. ICU Medical Soft-Contact Blood Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 139. ICU Medical Soft-Contact Blood Lancet Product
 Table 140. ICU Medical Recent Developments/Updates
 Table 141. Sarstedt Company Information
 Table 142. Sarstedt Description and Business Overview
 Table 143. Sarstedt Soft-Contact Blood Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 144. Sarstedt Soft-Contact Blood Lancet Product
 Table 145. Sarstedt Recent Developments/Updates
 Table 146. Sannuo Biosensor Company Information
 Table 147. Sannuo Biosensor Description and Business Overview
 Table 148. Sannuo Biosensor Soft-Contact Blood Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 149. Sannuo Biosensor Soft-Contact Blood Lancet Product
 Table 150. Sannuo Biosensor Recent Developments/Updates
 Table 151. Yuwell Medical Company Information
 Table 152. Yuwell Medical Description and Business Overview
 Table 153. Yuwell Medical Soft-Contact Blood Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 154. Yuwell Medical Soft-Contact Blood Lancet Product
 Table 155. Yuwell Medical Recent Developments/Updates
 Table 156. Tianjin Huahong Company Information
 Table 157. Tianjin Huahong Description and Business Overview
 Table 158. Tianjin Huahong Soft-Contact Blood Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 159. Tianjin Huahong Soft-Contact Blood Lancet Product
 Table 160. Tianjin Huahong Recent Developments/Updates
 Table 161. Suzhou Slink Medical Company Information
 Table 162. Suzhou Slink Medical Description and Business Overview
 Table 163. Suzhou Slink Medical Soft-Contact Blood Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 164. Suzhou Slink Medical Soft-Contact Blood Lancet Product
 Table 165. Suzhou Slink Medical Recent Developments/Updates
 Table 166. Shandong Lianfa Company Information
 Table 167. Shandong Lianfa Description and Business Overview
 Table 168. Shandong Lianfa Soft-Contact Blood Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 169. Shandong Lianfa Soft-Contact Blood Lancet Product
 Table 170. Shandong Lianfa Recent Developments/Updates
 Table 171. Puan Medical Company Information
 Table 172. Puan Medical Description and Business Overview
 Table 173. Puan Medical Soft-Contact Blood Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 174. Puan Medical Soft-Contact Blood Lancet Product
 Table 175. Puan Medical Recent Developments/Updates
 Table 176. Key Raw Materials Lists
 Table 177. Raw Materials Key Suppliers Lists
 Table 178. Soft-Contact Blood Lancet Distributors List
 Table 179. Soft-Contact Blood Lancet Customers List
 Table 180. Soft-Contact Blood Lancet Market Trends
 Table 181. Soft-Contact Blood Lancet Market Drivers
 Table 182. Soft-Contact Blood Lancet Market Challenges
 Table 183. Soft-Contact Blood Lancet Market Restraints
 Table 184. Research Programs/Design for This Report
 Table 185. Key Data Information from Secondary Sources
 Table 186. Key Data Information from Primary Sources
 Table 187. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Soft-Contact Blood Lancet
 Figure 2. Global Soft-Contact Blood Lancet Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Soft-Contact Blood Lancet Market Share by Type: 2025 & 2032
 Figure 4. Safety Product Picture
 Figure 5. Routine Product Picture
 Figure 6. Global Soft-Contact Blood Lancet Market Value by Length (US$ Million), 2021–2032
 Figure 7. Global Soft-Contact Blood Lancet Market Share by Length: 2025 vs 2032
 Figure 8. Standard Length Product Picture
 Figure 9. Short-length Product Picture
 Figure 10. Long-length Product Picture
 Figure 11. Global Soft-Contact Blood Lancet Market Value by Application (US$ Million), 2021–2032
 Figure 12. Global Soft-Contact Blood Lancet Market Share by Application: 2025 & 2032
 Figure 13. Newborn Screening
 Figure 14. Blood Glucose Test
 Figure 15. Rapid Complete Blood Count
 Figure 16. Others
 Figure 17. Global Soft-Contact Blood Lancet Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 18. Global Soft-Contact Blood Lancet Market Size (US$ Million), 2021–2032
 Figure 19. Global Soft-Contact Blood Lancet Sales (K Units), 2021–2032
 Figure 20. Global Soft-Contact Blood Lancet Average Price (US$/Unit), 2021–2032
 Figure 21. Soft-Contact Blood Lancet Report Years Considered
 Figure 22. Soft-Contact Blood Lancet Sales Share by Manufacturers in 2025
 Figure 23. Global Soft-Contact Blood Lancet Revenue Share by Manufacturers in 2025
 Figure 24. Top 5 and Top 10 Global Soft-Contact Blood Lancet Players: Market Share by Revenue in Soft-Contact Blood Lancet in 2025
 Figure 25. Soft-Contact Blood Lancet Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 26. Global Soft-Contact Blood Lancet Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 27. North America Soft-Contact Blood Lancet Sales Market Share by Country (2021–2032)
 Figure 28. North America Soft-Contact Blood Lancet Revenue Market Share by Country (2021–2032)
 Figure 29. United States Soft-Contact Blood Lancet Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Canada Soft-Contact Blood Lancet Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Europe Soft-Contact Blood Lancet Sales Market Share by Country (2021–2032)
 Figure 32. Europe Soft-Contact Blood Lancet Revenue Market Share by Country (2021–2032)
 Figure 33. Germany Soft-Contact Blood Lancet Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. France Soft-Contact Blood Lancet Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. U.K. Soft-Contact Blood Lancet Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Italy Soft-Contact Blood Lancet Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Russia Soft-Contact Blood Lancet Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Asia Pacific Soft-Contact Blood Lancet Sales Market Share by Region (2021–2032)
 Figure 39. Asia Pacific Soft-Contact Blood Lancet Revenue Market Share by Region (2021–2032)
 Figure 40. China Soft-Contact Blood Lancet Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Japan Soft-Contact Blood Lancet Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. South Korea Soft-Contact Blood Lancet Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. India Soft-Contact Blood Lancet Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Australia Soft-Contact Blood Lancet Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. China Taiwan Soft-Contact Blood Lancet Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Southeast Asia Soft-Contact Blood Lancet Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Latin America Soft-Contact Blood Lancet Sales Market Share by Country (2021–2032)
 Figure 48. Latin America Soft-Contact Blood Lancet Revenue Market Share by Country (2021–2032)
 Figure 49. Mexico Soft-Contact Blood Lancet Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Brazil Soft-Contact Blood Lancet Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Argentina Soft-Contact Blood Lancet Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Colombia Soft-Contact Blood Lancet Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Middle East and Africa Soft-Contact Blood Lancet Sales Market Share by Country (2021–2032)
 Figure 54. Middle East and Africa Soft-Contact Blood Lancet Revenue Market Share by Country (2021–2032)
 Figure 55. Turkey Soft-Contact Blood Lancet Revenue Growth Rate (US$ Million), 2021–2032
 Figure 56. Saudi Arabia Soft-Contact Blood Lancet Revenue Growth Rate (US$ Million), 2021–2032
 Figure 57. UAE Soft-Contact Blood Lancet Revenue Growth Rate (US$ Million), 2021–2032
 Figure 58. Global Sales Market Share of Soft-Contact Blood Lancet by Type (2021–2032)
 Figure 59. Global Revenue Market Share of Soft-Contact Blood Lancet by Type (2021–2032)
 Figure 60. Global Soft-Contact Blood Lancet Price (US$/Unit) by Type (2021–2032)
 Figure 61. Global Sales Market Share of Soft-Contact Blood Lancet by Application (2021–2032)
 Figure 62. Global Revenue Market Share of Soft-Contact Blood Lancet by Application (2021–2032)
 Figure 63. Global Soft-Contact Blood Lancet Price (US$/Unit) by Application (2021–2032)
 Figure 64. Soft-Contact Blood Lancet Value Chain
 Figure 65. Channels of Distribution (Direct Vs Distribution)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions